PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2013 | 57 | 4 |

Tytuł artykułu

Influence of fluoroquinolones on viability of Balb/c 3T3 and HepG2 cells

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
The cytotoxic potential of fluoroquinolones (enrofloxacin, ciprofloxacin, difloxacin, sarafloxacin, danofloxacin, norfloxacin and marbofloxacin) was investigated using mouse fibroblasts Balb/c 3T3 and human hepatoma HepG2 cell lines. The cells were exposed for 24, 48, and 72 h to drugs at eight concentrations ranged from 0.78 to 100 µg/mL. Four independent cytotoxicity assays were applied, in which various endpoints were assessed: mitochondrial activity - MTT reduction, lysosomal activity - neutral red uptake, total protein content, and cellular membrane integrity - lactate dehydrogenase release. Mean effective cytotoxic concentrations (EC₅₀) calculated at different time points from concentration-response curves ranged from 10 to 100 µg/mL. The most affected endpoint in both cell lines was mitochondrial activity. The EC₅₀₋MTT₋₇₂ₕ <10 µg/mL was found for difloxacin, marbofloxacin (fibroblasts), sarafloxacin, and norfloxacin (HepG2). The data shows that cytotoxicity of the fluoroquinolones appears after longer exposure of both cell cultures to these compounds.

Słowa kluczowe

Wydawca

-

Rocznik

Tom

57

Numer

4

Opis fizyczny

p.599-606,fig.,ref.

Twórcy

autor
  • Department of Pharmacology and Toxicology, National Veterinary Research Institute, 24-100 Pulawy, Poland
autor
  • Department of Pharmacology and Toxicology, National Veterinary Research Institute, 24-100 Pulawy, Poland
  • Department of Pharmacology and Toxicology, National Veterinary Research Institute, 24-100 Pulawy, Poland

Bibliografia

  • 1. Ayaki M., Iwasawa A., Niwano Y.: In vitro assessment of the cytotoxicity of six topical antibiotics to four cultured ocular surface cell lines. Biocontrol Sci 2012, 17, 93-99.
  • 2. Bertino J., Fish D.: The safety profile of the fluoroquinolones. Clin Ther 2000, 22, 798-817.
  • 3. Borenfreund E., Puemer J.A.: Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985, 24, 119-124.
  • 4. Bradford M.M.: A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of dye binding. Anal Biochem 1976, 72, 248-254.
  • 5. Durso L.M., Miller D.N., Wienhold B.J.: Distribution and quantification of antibiotic resistant genes and bacteria across agricultural and non-agricultural metagenomes. PLoS One 2012, 7, 1-12.
  • 6. Ferreira M.B., Myiagi S., Nogales C.G., Campos M.S., Lage-Marques J.L.: Time-and concentration-dependent cytotoxicity of antibiotics used in endodontic therapy. J Appl Oral Sci 2010, 18, 259-263.
  • 7. Fotakis G., Timbrell J.A.: In vitro cytotoxicity assays: comparison of LDH, neutral red. MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 2006, 160, 171-177.
  • 8. Garcia-Käufer M., Haddad T., Bergheim M.. Gminski R., Gupta P., Mathur N., Kümmerer K., Mersch-Sundermann V.: Genotoxic effect of ciprofloxacin during photolytic decomposition monitored by the in vitro micronucleus test (MNvit) in HepG2 cells. Environ Sci Pollut Res 2012, 19, 1719-1727.
  • 9. Hernández-Arteseros J.A., Barbosa J., Compaňó R., Prat M.D.: Analysis of quinolone residues in edible animal products. J Chromatogr A 2002, 945, 1 -24.
  • 10. Herold C., Ocker M., Ganslmayer M., Hahn E.G., Schuppan D.: Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer 2002, 86, 443-448.
  • 11. Hincal F., Gürbay A., Favier A.: Biphasic response of ciprofloxacin in human fibroblast cell cultures. Nonlinearity Biol Toxicol Med 2003, 1, 481-492.
  • 12. Holtom P.D., Pavkovic S.A., Bravos P.D., Patzakis M.J., Shepherd L.E., Frenkel B.: Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro. J Orthop Res 1999, 18, 721-727.
  • 13. Iwasawa A., Ayaki M., Niwano Y.: Cell viability score (CVS) as a good indicator of critical concentration of benzalkonium chloride for toxicity in cultured ocular surface cell lines. Regul Toxicol Pharmacol 2013, 66, 177-183.
  • 14. Kamat A., Lamm D.L.: Antitumor activity of common antibiotics against superficial bladder cancer. Urology 2004, 63, 457-460.
  • 15. Kloskowski T., Gurtowska N., Nowak M., Joachimiak R., Bajek A., Olkowska J., Drewa T.: The influence of ciprofloxacin on viability of A549, HepG2, A375.S2, B16 and C6 cell lines in vitro. Acta Pol Pharm 2011, 68, 859- 865.
  • 16. Korzeniewski C., Calleawert D.M.: An enzyme release assay for natural cytotoxicity. J Immunol Methods 1983, 64, 313-320.
  • 17. Kruse M., Kilic B., Flik B., Stahlmann R.: Effect of quinupristin/dalfopristin on 3T3 and Eahy926 cells in vitro in comparison to other antimicrobial agents with the potential to induce infusion phlebitis. Arch Toxicol 2007, 81, 447-452.
  • 18. Licata A., Randazzo C., Morreale I., Butera G., D'Alessandro N., Craxi A.: Fluoroquinolone-induced liver injury: three new cases and a review of the literature. Eur J Clin Pharmacol 2012, 68, 525-532.
  • 19. Liguori M.J., Blomme E.A.G., Waring J.F.: Trovafloxacin- induced gene expression changes in liver-derived in vitro systems: comparison of primary human hepatocytes to HepG2. Drug Metab Dispos 2008, 36, 223-233.
  • 20. Martinez M., McDermott R., Walker R.: Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Vet J 2006, 172, 10-28.
  • 21. Mestorino N., Marchetti M.L., Turic E., Pesoa J., Errecalde J.: Concentrations of danofloxacin 18% solution in plasma, milk and tissues after subcutaneous injection in dairy cows. Anal Chim Acta 2009, 637, 33-39.
  • 22. Minta M., Wilk I., Żmudzki J.: Inhibition of cell differentation by quinolones in micromass cultures of rat embryonic limb bud and midbrain cells Toxicol in Vitro 2005, 19, 915-919
  • 23. Miolo G., Viola G., Vedaldi D., Dall'Acqua F., Fravolini A., Tabarrini O., Cecchetti V.: In vitro photocytotoxic properties of new 6-desfluoro and 6-fluoro-8-methylquinolones. Toxicol in Vitro 2002, 16, 683-693.
  • 24. Mosmann T.: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 1983, 65, 55 -63.
  • 25. Scheers E.M., Ekwall B., Dierickx P.J.: In vitro long-term cytotoxicity testing of 27 MEIC chemicals on HepG2 cells and comparison with acute human toxicity data. Toxicol in Vitro 2001, 15, 153-161.
  • 26. Sukul P., Spiteller M.: Fluoroquinolone antibiotics in the environment. Rev Environ Contain Toxicol 2007, 191, 131-162.
  • 27. Weyermenn J., Lohmann D., Zimmer A.: A practical note on the use of cytotoxicity assays. Int J Pharm 2005, 288, 369-376.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-3dce20c0-07c6-41d5-ba05-f050757ed2ef
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.